France Dialysis Market is expected to reach USD 6.71 billion by 2030

The surge in diabetes and hypertension cases will propel the dialysis market during the forecast period.

France Dialysis Market is valued at USD 5.35 billion in 2023, and is expected to reach USD 6.71 billion by 2030, with a CAGR of 3.3% from 2024 to 2030, according to new research by Next Move Strategy Consulting.

The surge in diabetes and hypertension cases in the country contributes significantly to the growth of the market. These chronic conditions, especially when unmanaged, can lead to kidney damage and eventually chronic kidney disease (CKD). 

With the increasing prevalence of diabetes and hypertension, there is a corresponding rise in the incidence of CKD, necessitating the use of dialysis as a crucial therapeutic intervention. The expanding patient pool with these comorbidities underscores the importance of dialysis services in managing kidney-related complications, driving the demand for dialysis treatments.

Moreover, the escalating incidence of Chronic Kidney Disease (CKD) serves as a prominent driver for the France dialysis market. CKD, characterized by a gradual loss of kidney function over time, has witnessed a steady rise due to factors like aging populations, lifestyle-related conditions, and increased awareness leading to early diagnosis.

As CKD prevalence continues to grow, the demand for dialysis services, encompassing both hemodialysis and peritoneal dialysis, is experiencing a corresponding increase. This surge in demand positions the dialysis market at the forefront of addressing the healthcare needs of individuals grappling with CKD, driving market expansion and technological advancements to meet the rising treatment demand.

However, France dialysis market is restrained with the inherent risk of infections and complications associated with these procedures. Poor adherence to stringent hygiene practices and inadequate sterilization measures can elevate infections, posing a threat to patient health.

Additionally, complications arising from the dialysis process itself can contribute to treatment challenges. Addressing these risks through rigorous quality control measures, training healthcare professionals, and promoting adherence to established protocols is essential to enhance the safety profile of dialysis treatments, fostering better patient outcomes and confidence in the market.

On the contrary, introduction of at-home dialysis solutions is creating growth opportunity for the market, where patients can conveniently use dialysis solutions at home. This approach enhances patient comfort, reduces the need for frequent hospital visits, and provides a flexible kidney care option.

As more individuals prefer the convenience of managing their dialysis in the comfort of their homes, companies that provide user-friendly and portable dialysis equipment stand to capture a significant market share. By addressing the growing demand for home-based healthcare solutions, the dialysis market can attract a broader customer base and foster long-term patient satisfaction, contributing to overall market growth.

Request a sample here:

According to the report, leading players in the France dialysis market include Baxter International, Inc., DaVita Inc., Nikkiso Co. Ltd., NxStage Medical, Inc., Asahi Kasei Corporation, Medicators, Inc, Fresenius Medical Care AG & Co. KGaA, Nipro Corporation, B. Braun Avitum AG, Diaverum Deutschland GmbH, and others.

Key Insights from the France Dialysis Market Report:

  • The information related to key drivers, restraints, and opportunities and their impact on the France dialysis market is provided in the report.

  • The value chain analysis in the market study provides a clear picture of the roles of each stakeholder.

  • The market share of the France dialysis market and their competitive analysis are provided in the report. 

Share this post?


No comment available , be the first one!

Leave a Reply